Insulet
PODD
#1019
Rank
S$25.33 B
Marketcap
$361.21
Share price
3.90%
Change (1 day)
26.10%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $2.33

According to Insulet's latest financial reports the company's current EPS (TTM) is $2.33. In 2022 the company made an earnings per share (EPS) of $0.09485 a decrease over its 2021 EPS that were of $0.31.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.332352.75%
2022$0.09485-69.57%
2021$0.31109.09%
2020$0.15-38.89%
2019$0.24200%
2018$0.08130-113.04%
2017-$0.62-9.8%
2016-$0.69-60.77%
2015-$1.7639.78%
2014-$1.2612.05%
2013-$1.12-23.15%
2012-$1.4610.2%
2011-$1.33-36.36%
2010-$2.09-36.63%
2009-$3.29-29.36%
2008-$4.66-86.74%
2007-$35.16-64.04%
2006-$97.76122.23%
2005-$43.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.74-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.38-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.33-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.09 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.03 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.69 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$7.36 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA